Announcements Trials
Browse Landscape

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Myeloid 1Dermatologic 1

Conditions

Neoplasms 271Breast Neoplasms 264Lung Neoplasms 130Prostatic Neoplasms 114Colorectal Neoplasms 108Carcinoma, Non-Small-Cell Lung 103Pancreatic Neoplasms 67Carcinoma, Hepatocellular 53Ovarian Neoplasms 51Stomach Neoplasms 49Multiple Myeloma 49Hematologic Neoplasms 49Urinary Bladder Neoplasms 47Brain Neoplasms 45Melanoma 42Leukemia, Myeloid, Acute 42Head and Neck Neoplasms 40Esophageal Neoplasms 40Colonic Neoplasms 38Disease 37Liver Neoplasms 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Rectal Neoplasms 34Lymphoma 32Neoplasm Metastasis 31Leukemia, Lymphocytic, Chronic, B-Cell 30Endometrial Neoplasms 30Recurrence 28Kidney Neoplasms 28Uterine Cervical Neoplasms 27

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Arthritis, Psoriatic × 90 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

NCT02450396 2026-03-27

EGR2

Assistance Publique - Hôpitaux de Paris

Withdrawn
Myeloid

Arthritis, Rheumatoid, Lupus Erythematosus, Systemic, Mastocytosis, Myositis, Sjogren's Syndrome, Vasculitis, Arthritis, Psoriatic, Antiphospholipid Syndrome, Spondylarthritis, Rare Diseases, Scleroderma, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡